Repligen (RGEN) Tops Q1 EPS by 26c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Repligen (RGEN) Tops Q1 EPS by 26c

Repligen Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

May 4, 2021 7:30 AM EDT

Reported revenue was $142.8 million for the quarter, representing year-over-year growth of 88% and organic growth of 69%Growth driven by combination of COVID-related demand, base business strength and acquisition revenue

WALTHAM, Mass., May 04, 2021 (GLOBE NEWSWIRE) --  Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter ended March 31, 2021. Provided in this press release are financial highlights for the quarter, updates to our financial guidance for the year 2021, and access information for todays webcast and... More